WP1 has been set the objective of providing the Alliance with an overall scientific and governance structure that will facilitate collaboration, support, and effective supervision among all our partners. Such a clear statement of goals and expected outcomes will ensure the quality and timeliness of deliverables and that the project’s objectives are effectively managed.
- Coordinating all activities, logistics, and tracking and reporting progress;
- Approving the project’s deliverables and the processes they involve;
- Ensuring that mechanisms are put in place for overall contractual, financial, ethical, administrative management, and to resolve conflicts;
- Creating and organizing internal communication channels and tools for disseminating information about successful results (together with WP7);
- Aligning all aspects of the project to ensure that all stakeholders and partners are fully engaged;
- Identifying short-term and long-term sustainability strategies.
AEMPS, Amgen, AP-HP, Barts Health, Bayer, BfArM, Celgene, EAPM, EBMT, EHA, ELN, EORTC, Erasmus MC, ERIC, FisM Onlus, GFM, GMV, Goethe University, GPOH, GRAALL, GRL-SANGER, HHU, HULAFE, IECSCYL-IBSAL, IJC, Janssen, LeukaNET, LMU, LYSA, MediSapiens, MediUni Wien, Menarini, MML, MU, Newcastle University, NICE, Novartis, OPBG, SYNAPSE, Takeda, UCAM, Ulm University, UNIBO, UNITO, University of Helsinki, University of Navarra, University of Rome Tor Vergata, University of York, VHIO, VIB, VUMC.
- Established the Ethics Advisory Board and External Advisory Panel. Reference to the advisors for the development of HARMONY’s “modus operandi” on data privacy and the establishment of ties with other international initiatives;
- Coordinated and aligned on a common terminology: HARMONY and re-use of data;
- Developed a procedure for the submission and approval on bench-to-bedside research proposals;
- Developed of the legal framework for data sharing with Associated members: Associated Members’ Engagement Framework and Associated Members’ Data Sharing Agreement;
- Contacted 55 Associated Members. Positive reply and AMEF signed from 14 organizations. Another 19 organizations on signature process;
- Made agreements with industry partners for sharing published clinical trial data in existing bench-to-bedside projects;
- Coordinated activities, the development of management internal procedures and the adjustment to changes: submitted the first amendment;
- Submitted deliverables to the Innovative Medicine Initiative, funder of the HARMONY Alliance.